MAPT and breast carcinoma: The IC50s of PTX vary between 2–200 nM in breast cancer cells due to differential basal level expressions of β-tubulin subunits of microtubules101–103, sensitivity of PTX toward binding with β-tubulin101, the expression of tau proteins involved in microtubule polymerization104, and HER2 expression levels105.